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Most ofthe composites and sealants used in dentistry are based on bisphenol A diglycidylether
methacrylate (Bis-GMA). Reports revealed that in situ polymerization is not complete and that
free monomers canbe detected bydifferentanalytic methods. Concerns about the estrogenicity of
bisphenol A (BPA) and other aromaticcomponents leached from commercial products have been
expressed. We studied biphenolic components-eluted from seven composites and one sealant
beforeand after in vitropolymerization using HPLC and gas chromatography/mass spectrometry
and we investigated how pH modifications affect the leaching ofthese components. We found
BPA (maximal amount 1.8 p/mgdental material), its dimethacrylate derivative (Bis-DMA, 1.15
pg/mg), bisphenol A diglycidylether (6.1 pg/mg), Bis-GMA (2.0 pg/mg), and ethoxylate and
propoxylate ofbisphenol A in media in which samples of different commercial products were
maintained undercontrolled pH and temperature conditions. Our results confirm the leaching of
estrogenic monomers into the environment by Bis-GMA-based composites and sealants in con-
centrations atwhich biologiceffects have been demonstrated in in vivoexperimental models. The
main issuewith implications forpatientcare and dentistresponsibility is to fuirther determine the
clinical relevance of this estrogenic exposure. Key words Bis-GMA, bisphenol A, bisphenol A
dimethacrylate, dental composites and sealants. Environ Health Perspect 108:21-27 (2000).
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Polycarbonates, epoxy, and methacrylic
resins are synthesized by reactions between
individual chemicals, resulting in polymers
with distinct physicochemical characteristics.
As biomaterials they have multiple uses in
human health applications; for instance, as
manufactured products, for example, intraoc-
ular lenses (1), cements for trauma surgery
(2,3), or bisphenol A (BPA)-based filling
materials in preventive (4,5) and restorative
dentistry (6). The latter requires extensive
manipulation and in situpolymerization.
From a toxicologic standpoint, the
migration ofoligomers, monomers, and the
precursors of synthetic polymers and other
low-weight molecules from polymer net-
works must be carefully controlled because
some of them can react with biologically
important molecules. This is the case with
BPA and bisphenol A diglycidylether
(BADGE), which form adducts on DNA
(7-9). BPA also binds to the estrogen
receptor (10).
The estrogen receptor-mediated effects
of BPA and related diphenyls make their
detection an important issue. A study pub-
lished in 1936 (11) demonstrated that
diphenyl and diphenylmethanes had estro-
genic activity in ovariectomized rats. Both
compounds contained two hydroxyl groups
in para positions. Later, Reid and Wilson
(12) characterized further 4,4'-dihydroxy
diphenylmethane-derived compounds with
estrogenic activity, including molecular
modifications of BPA with different hor-
monal activity. BPA mimics 1713-estradiol
in vitro (10,13-16) as well as in estrogen tar-
get organs in animal models (17-19). BPA
mimicked natural and synthetic estrogens
such as diethylstilbestrol in experimental
models other than breast and uterine tissue
(20-22). Besides BPA, its dimethacrylate
derivative Bis-DMA (16,23,24), BADGE
(16), and related diphenylalkanes (25) are
estrogenic in different bioassays and sys-
tems. Bis-GMA increased uterine wet
weight and uterine collagen content in
ovariectomized mice (26) and induced cell
proliferation on MCF-7 cells (27), although
previous works were unable to show any
proliferative effect of Bis-GMA except
under extreme pH conditions (16).
BPA was detected in a culture medium
for yeasts as an estrogenic contaminant that
leached from polycarbonate bottles during
autoclaving (10). Also, BPA and other aro-
matic monomers are contaminants in wine
and mineral water stored in plastic contain-
ers (28,29), in microwave susceptors (30), in
food from cans coated with epoxy resin lac-
quers (15), and in canned oily foods (31).
More recently, we found that BPA and Bis-
DMA were responsible for the estrogenicity
ofsome commercial composites and sealants
used in dentistry; they leached into the sali-
va of treated patients (16). These results
have been confirmed by Arenholt-Bindslev
et al. (32) and Fung et al. (33), who found
BPA in saliva samples collected immediately
after the placement ofDelton LC (batch no.
940218; Dentsply, York, PA). A yeast-based
bioassay confirmed the estrogenic activity of
these saliva samples (32). In addition to
BPA (16,32,33), Bis-DMA and Bis-GMA
also leached from polymerized composites
and sealants, and their presence among elut-
ed compounds was demonstrated after in
vitro polymerization (34-39). Leaching of
components from composites and sealants
may occur during the setting period of the
resin and by the degradation ofpolymerized
materials (40). Bis-DMA can also be a
source of BPA because the enzymatic activi-
ty ofsaliva, esterases, extreme pH, and saliva
storage can hydrolyze the dimethacrylate
derivative (8,41). Figure 1 shows the chemi-
cal structure of BPA and related aromatic
compounds.
The aim of the present study was to
determine aromatic components eluted by
in vitro polymerized Bis-GMA-based com-
posites and sealants, to investigate how pH
modifications affect the leaching of these
components from the initial commercial
product, and to assess their presence prior to
polymerization. We found that BPA, Bis-
DMA, BADGE, and Bis-GMA, among
other aromatic components, leached from
composites and sealants both before and
after polymerization; their presence was
always confirmed by gas chromatography/
mass spectrometry (GC/MS).
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Materials and Methods
Equipment. F6r HPLC we used a Konik
model KNK-500 series A apparatus (Konik
Instruments, Barcelona, Spain) connected
with a Konik detector UVIS-200 and an HP
integrator HP-3394A (Hewlett-Packard,
Seville, Spain). For GC/MS we used a Fisons
Carlo Erba 8000 chromatograph (Fisons
Carlo Erba, Milan, Italy) and Fisons VG
platform mass spectrometer.
Reagents. Acetonitrile (Panreac Quimica
SA., Barcelona, Spain) was the HPLC
reagent. Reference standards BPA (4,4'-iso-
propopylidenediphenol, FW 228.31), Bis-
DMA (FW 364.44), bisphenol A etoxylate
(EBPA; FW316), and bisphenol A propoxy-
late (PBPA; FW 344) were purchased from
Aldrich-Chemie (Albuch, Germany).
BADGE (FW 340.45) was a gift from
Gairesa, S.A. (La Corufna, Spain); Bis-DMA
(FW 364.44) was obtained from NUPOL
(Ivoclar, Liechtenstein). Analytical HCI,
NaHCO3, and NaOH were purchased from
E. MerckA.G. (Darmstadt, Germany).
Dental material. We used an Optilux
VCL-300 polymerization lamp from
Demetron Research Corporation (Danbury,
CT). Its luminescence was tested and gave
mean values of 435 mW/cm2. Polymerized
composite samples were formed using 0.5-
cm diameter glass cylinders 1 cm high so
that all the samples presented the same geo-
metric shape.
Composites and sealants. Dental materi-
als tested in this study were selected from
among commercial products available in the
Spanish market. They were selected with the
exclusive condition that the producer indi-
cated that they were Bis-GMA-based resins.
The composites and sealant studied are as
follows:
* Charisma (batch 054; Heraeus Kulzer,
Wehrheim, Germany)
* Pekalux (batch 1891D; Bayern Leverkusen,
Germany)
* Polofil (batch 3318; Voco, Cuxhaven,
Germany)
* Silux-Plus (batch 5702Y; 3M, St. Paul, MN)
* Z-100 (batch 5904B3; 3M, St. Paul, MN)
* Tetric (batch 460180; Ivoclar, Schaan,
Liechtenstein)
* Brillant (batch CH596; ColteneWhaledent,
Alstatten, Switzerland)
* Delton (batch 940218).
HPLC analysis. For HPLC analysis, we
used a C-18 column (flow of 1 mL/min)
and a UV detector at 280 nm. We used the
following solvents: acetonitrile/water 1/1
(v/v) for phase A and acetonitrile for phase
B. We used helium gas, a temperature of
25°C, and an injection volume of20 pL. The
gradient was 100% at 0 min (phase A),
100% at 15 min (phase B), and 100% at 17
min (phase A). The total duration of the
chromatogram was 17 min.
GCIMSanalysis. Forthe GC/MS analysis,
we used a 15-m methyl silica capillarycolumn
(OV-P); an injector temperature of 240°C;
and an ion source temperature of 200°C. The
temperature gradient was as follows: initial
temperature of 80°C (2 min); final tempera-
ture of 320°C; and rate of temperature
increase of10°C/min. Thecarrier gaswas heli-
um, the flow was 1.2 mL/min, and the injec-
tionvolumewas 0.2 pL.
Qualitative analysis ofBPA andrelated
aromatic compounds. We analyzed solutions
ofreference standard products in ethanol by
HPLC at concentrations between 10-7 and
10-3 mol/L. Mean retention times of the
products are listed in Table 1. In the
GC/MS chromatography, mean retention
times ± SD (minutes) for each of the refer-
ence standards were 21.5 ± 0.2 for BPA;
22.8 ± 0.2 for Bis-GMA; 23.9 ± 0.1 for
EBPA; 26.8 ± 0.2 for Bis-DMA; 27.7 ± 0.2
for PBPA, and 27.9 ± 0.3 for BADGE.
Dental methodology. Nonpolymerized
samples were weighed (100 mg ofeach com-
posite and 50 mg ofthesealant), andsamples
were carefully decanted into the appropriate
topaz glass vial to which 1 mL of distilled
water was then added. A glass distillator and
glass containers were used for water treat-
ment and storage. After vigorous agitation,
samples were left to settle for 24 hr.
Polymerized samples (100 mg) of each
composite studied were compacted into a
small glass cylinder to take on its geometric
form. Thecylinder wasplaced on apetri plate
for compacting. The composite was polymer-
ized to a 2-mm depth. Fifty milligrams ofthe
sealant product was placed on a petri dish.
Polymerization was immediately performed
for40 secbysituatingthe front ofthelamp in
close contact with the opposite side of the
glass to that onwhich thecylinder wasplaced.
Samples were extracted from the cylinder by
applying pressure and were moved to avial to
continue the analysis. In all cases 1 mL dis-
tilled water was then added, and after vigor-
ousagitation was left to settle for24 hr.
The pH of the medium and the poly-
merized/nonpolymerized status were the
paired variables. The pH values of 1, 7, 9,
and 12 were regulated with 1 M HCI, dis-
tilled water, saturated solution ofNaHCO3,
and 1 M NaOH, respectively. The tempera-
ture used for each of these pH values was
37°C. Three samples of each commercial
product were analyzed under these eight
physicochemical conditions.
Results
Quantitative analysis ofBPA and related
compounds. The detection andquantification
limits were calculated in accordance with 10
concordant measurements of standard solu-
tions for each ofthe products analyzed (BPA,
EBPA, PBPA, BADGE, Bis-GMA, and Bis-
DMA). Table 1 shows the detection limits
Figure 1. Chemical structures of bisphenol A and related compounds.
Table 1. Detection limits and equations ofthe calibration curves by HPLC.
Detection Quantitation
Retention limit limit Curve equation
Product time (minma (pg/mL) (pg/mL) (y= aox+ a) Pb
BPA 2.76±0.16 0.20 0.23 y=3.111 xlO9x 0.999
+71,423
EBPA 3.86 ± 0.12 0.40 0.50 y= 1.744x 1010x 0.997
+ 351,794
PBPA 5.24 ± 0.15 1.70 3.40 y=4.296 x 1010x 0.998
- 1,492,319
BADGE 7.10 ±0.24 0.90 1.20 y=4.519x 1O9x 0.997
+ 190,475
Bis-GMA 7.60 ± 0.24 0.30 0.54 y= 1.719 x 1010x 0.999
- 49,423
Bis-DMA 10.30 ± 0.10 0.40 0.80 y= 2.423 x 1010x 0.999
+ 1,638,803
'Mean ± SD. hCorrelation coefficient.
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that corresponded to the value 30 (42)
deduced from experiments performed to
establish the linearity of the detector. Peak
areas were determined by using the integrator
HP-3394. Calculations were made according
to International Union of Pure and Applied
Chemistry recommendations. Detection lim-
its ranged from 0.20 pg/mL for BPA to 1.70
pg/mL for PBPA.
Calibration curve parameters and lineari-
ty of the detector responses are shown in
Table 1 togetherwith the estimated quantifi-
cation limits. Standard solutions of variable
concentration between 10-7 and 10-3 mol/L
were prepared and 20 pL ofeach was inject-
ed into the HPLC. Calibration curves were
constructed from 10 concordant measure-
ments and were used for the subsequent
quantification in the analyses.
The accuracy of the chromatographic
method was studied in the same conditions
and was expressed as a percentage ofrecovery.
The concentrations were calculated from the
area ofthe peak and the mean response factor
for each product (Table 2). Recovery percent-
ages were always above 95% and ranged from
95.7% for BPAto 100.2% for EBPA.
HPLCand GC/MS qualitative analysis.
The compounds were first identified in
HPLC from the retention times of each
product. Figure 2 shows the chromatograms
of polymerized Pekalux and Silux compos-
ites and the Delton sealant at pH 7. Peaks
corresponding to the retention times of
BPA, Bis-GMA, BADGE, PBPBA, EBPA,
and Bis-DMAwere observed. These findings
were confirmed by GC/MS in all ofthe sam-
ples for which HPLC chromatograms
showed the corresponding peaks. Figure 3
shows chromatograms (GC/MS) of com-
pounds detected in the Delton sealant.
HPLC quantitative analysis. To deter-
mine how pH modifications affected the
leaching ofcomponents both from the initial
nonpolymerized commercial product and
from the in vitro polymerized product, 20-
,L aliquots ofthe 1-mL water suspension in
the different physicochemical conditions
defined were analyzed by HPLC. Tables
3-10 list the mean ± SD (in micrograms per
milliliter) of the concentrations of the aro-
matic components (BPA, EBPA, PBPA,
BADGE, Bis-GMA, and Bis-DMA) quanti-
fied in each commercial sample before (non-
polymerized) and after polymerization
(polymerized) in four pH conditions (acid,
pH 1; neutral, pH 7; and alkaline, pH 9
and pH 12).
Table 2. Confirmation of accuracy in the analytic technique by HPLC.
Parameters BPA EBPA PBPA BADGE Bis-GMA Bis-DMA
Real concentration (pg/mL) 22.8 31.6 34.4 85 51.2 36.4
Responsefactor 5.54x 10-5 2.53x10- 1.54x10-6 5.57x10-5 3.61 x10-5 8.20x 10-6
Concentration found (pg/mL) 21.8 31.6 34.33 82.71 51.09 36.26
Recovery (%) 95.65 100.2 99.8 97.3 99.7 99.6
Standard deviation Icy) 0.37 0.66 2.73 5.73 2.62 1.48
Coefficient ofvariation (%) 0.17 2.3 7.95 6.93 5.38 4.09
Standard error 0.30 0.54 2.44 4.68 2.35 1.21
Relative error 2.74 3.4 13.86 11.02 8.96 6.52
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Data indicate the amount ofcompounds
leached for a 24-hr period, expressed in
micrograms per milliliter medium; because
thevolume ofthe sample was 1 mL, the data
shown represent the total amount ofleached
components for 100 mg composite and 50
mg sealant. BPA was detected in all of the
commercial samples studied both before and
after polymerization. The maximal amount
of BPA (1.8 pg/mg) was found in nonpoly-
merized Charisma independent of the pH.
The lowest levels ofBPAwere found in non-
polymerized Polofil. In addition, polymer-
ized Tetric and nonpolymerized Brillant
were negative for this monomer at neutral
pH. BADGE was found in all the samples
(maximal 6.1 pg/mg in polymerized Delton)
except nonpolymerized Charisma. The
oligomer Bis-GMA was found in all poly-
merized and nonpolymerized samples except
Silux samples, which were also negative for
Bis-DMA and PBPA. However, Silux sam-
ples showed the presence of EBPA both
before and after polymerization.
With respect to the presence of Bis-
DMA, this monomer was found in all ofthe
samples studied except the Brillant and Silux
products. All others showed variable
amounts ofBis-DMA (maximal 1.15 pg/mg
for polymerized Pekalux at the highest alka-
line pH) after polymerization (Charisma,
Pekalux, Polofil, Tetric, Z-100, and Delton),
and, in Polofil and Delton, also before poly-
merization. Finally, the presence of PBPA
and EBPA was less frequent. PBPA was
exclusively detected in nonpolymerized sam-
ples of Pekalux and in polymerized Delton.
EBPA was detected in nonpolymerized
Pekalux and Silux and in polymerized
Delton, Silux, and Tetric.
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Figure 2. HPLC chromatograms of polymerized samples of (A) Pekalux (Bayer, Leverkusen, Germany) and (B) Silux (3M, St. Paul, MN) composites and (C) Delton
(Dentsply, York, PA) sealant. Polymerized samples were left to settle in distilled water at pH 7, 371°C, for 24 hr. Leachable component corresponded to BPA,
EBPA, PBPA, BADGE, Bis-GMA, and Bis-DMA.
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Discussion
The leaching ofaromatic components from
composites and sealants polymerized in vitro
poses a clinical problem because of the
demonstrated estrogenicity of some biphe-
nolic compounds. We studied seven com-
posites and one sealant and detected BPA in
all of the commercial products analyzed,
although some acid and neutral conditions
were less conducive to its release. Regarding
the release of other biphenolic compounds
(25), all samples that showed detectable lev-
els of Bis-DMA were also positive for the
presence ofBis-GMA, BADGE, and BPA.
The elution of leachable compounds
from samples greatly depends on the poly-
merization conditions (43), and standardiza-
tion ofthese conditions was thus an essential
first step in our study design. The polymer-
ized and nonpolymerized resins were left
undisturbed at rest and were submitted only
to variable pH at a controlled temperature,
so that the components migrated to the liq-
uid phase without the use of organic sol-
vents. Methanol (35,44,45) and water/
ethanol combinations (46,47), a tonic drink
(48), and food-simulating chemicals (47)
have been reported in the literature as appro-
priate media for the extraction of polymer-
ized composites. We used water in this study
in an attempt to reproduce in vitro the con-
ditions to which Bis-GMA-based resins are
submitted when utilized in dentistry, as in
our earlier work (16). Nevertheless, the use
of water may result in lower levels of
monomer elution than those found when
organic solvents are applied, and this would
account for quantitative differences between
ourfindings and those ofother authors.
The effect ofpH variations on the leach-
ing of monomers in dental microenviron-
ments was reported previously (49). Extreme
pH has some influence on the extraction
of components from polymerized and non-
polymerized samples. In addition, leached
components may be broken down in the
stomach. The role of pH in the elution of
compounds is evident in the results of the
presentstudy, especiallyforcertain monomers
in polymerized samples. For example, elu-
tion of BPA increased as the pH become
more alkaline and was greater at pH 12 than
at any other pH value. BPA values ranged
between 0.014 (1.4 pg/mL) and 0.195
pg/mg (19.5 pg/mL) for the Charisma com-
posite, between undetectable and 0.113
pg/mg (11.3 pg/mL) for Brillant, and
between 0.129 (12.9 pg/mL) and 1.161
pg/mg (116.1 pg/mL) for the Tetric prod-
uct, at pH 7 and 12, respectively. Although
in the present study we highlight the data for
BPA, these enhanced elution values at
extreme pH were similar to those of other
components found in most of the compos-
ites studied. Interestingly, when Bis-DMA
was subjected to pH 11 for 30 min at 50°C,
an almost 100% conversion ofBis-DMA to
BPAwas reported by Schmalz (41), who also
showed the effect ofsaliva and esterase treat-
ment on the hydrolysis of the Bis-DMA to
BPA. Another recent study (50) confirmed
that Bis-DMA was readily hydrolyzed to
BPA when stored for 4 months in saliva at
-20°C, whereas BPA was stable under the
same storage conditions.
We stress that the composites and
sealants are unstable and that to a greater or
lesser degree, dependingon the aggressiveness
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ofthe medium, it is always possible to detect
the elution of monomers, olygomers, and
precursors. These findings confirm reports
that in vitro polymerization is not complete
and that free monomers can be detected by
different analytic methods (38,39,51,52).
Several publications have appeared since our
first report on BPA and Bis-DMA leaching
from the Delton sealant (16) that may help
to define a position regarding monomer
leachability and their hormonal activity in
vivo. For instance, Hamid and Hume (38)
and Nathanson et al. (39) failed to find BPA
leaching from several polymerized sealants,
whereas Manabe et al. (53) found BPA
Som El+
TIc
6.70.7
27.06
21.30
20.25
14.0 10.40 18.00 20.0 22.00 24.00 25.00 2.500 20.00
DELTON
213
11t
Sc. El+
1.025s
214
ns L
50 00 70 to 30 160 11o125150to 1A iio,'I*o i;oto ' P'O't i30s2 2- 0n
Figure 3. Chromatograms by gas chromatography/mass spectrometry of a polymerized sample of the
Delton (Dentsply, York, PA) sealant shown in Figure 2. (A) Peaks eluted at times 21.7, 22.8, and 27.0 min
were identified as (B) BPA, (C) Bis-GMA, and (D) Bis-DMA, respectively. continued
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leaching from unpolymerized dental materi-
als and Arenholt-Bindslev et al. (32) and
Fung et al. (33) found BPA in the saliva of
patients treated with Delton.
Hamid and Hume (38) concluded that
earlier concern about the possible adverse
effects of BPA was questionable, whereas
Nathanson et al. (39) claimed that there was
no current need to use different sealants or
restrict their use. Recently, we refuted point
by point (54) the observations ofNathanson
(39) and called for further research to
address this issue. In the current study we
used a reverse-phase HPLC method that
substantially differs from the methods used
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the wavelength of confirmed by GC/MS and these techniques
where aromatic must be used correctly. Manabe et al. (53)
iterference from pointed out that derivation with tri-
Dunds is avoided. methylsilyl was necessary to detect BPA in
m have been used dental material (53).
nation of triethyl- In fact, Bis-DMA was found by
te and Bis-GMA Nathanson et al. (39) in appreciable amounts
the other com- (1.23 pg/mg in Delton and 0.39 pg/mg in
.e., BADGE, Bis- Defender sealants, respectively), confirming
wed absorbance at previous reports ofthe presence ofthis com-
at 280 nm with- pound leaching from composites and
al ethylene glycol sealants (16,35,56). Bis-GMA was also
which had a spec- found in the eluates of polymerized sealant
at 218 nm (48). samples by Hamid and Hume (38) and
c peaks must be Nathanson et al. (39), as has been found for
other Bis-GMA-based resins (16,35-37,
48,56). Bis-DMA and Bis-GMA are two
Scan El+ ,.eise explanations for the estrogenicity of sealant
and composite eluates. In addition to BPA
(10,11,15-17), its dimethacrylate derivative
Bis-DMA (16,23,24), the oligomer Bis-
GMA (27), and other bisphenol A-related
monomers (25,57) are all estrogenic. The
cumulative estrogenic effect ofthese aromat-
ic compounds should also be ofconcern.
With respect to the implications for
patient care and dentist responsibility, more
data must be gathered before a complacent
attitude toward this hazard is adopted. As
Soderholm and Mariotti (58) proposed, the
main issue is to determine whether the estro-
genic effects ofdental sealant and composite
monomers have any real clinical conse-
quences. This concern should be addressed
by new studies that focus on the toxicity-
estrogenicity-of leached monomers,
352 oligomers, and precursors, similar to the ,,|-, , sz paper recently published by our group (25).
It will be difficult to give an apriori pre-
diction ofthe risk to human health posed by
Scan El+ 349 4.196 such exposures, but new data may help assess
this exposure within the general risks attrib-
utable to xenoestrogens and especially BPA
(59). Four recent observations have raised
concern about the estrogenicity of bisphe-
nols. First, a more potent in vivo BPA effect
has been demonstrated as compared to previ-
364 ous in vitro assays (19,21). For instance, 3
days ofexposure to microgram levels ofBPA
(60-100 pg/rat/day) released from capsules
350 promoted cellular proliferation in rat uterus
and vagina, which showed molecular and
morphologic alterations nearly identical to
those induced by estradiol (60). The biologic
significance ofthe 179 pg BPA eluted from a
100-mg polymerized sample of commercial
l365 composite in our study should be considered
from this standpoint. Second, BPA seems to
351 act on other target organs as well as the obvi-
_ i3,6
ous organs [breast and uterus (21,22,49,61)].
ko46a WO m80 j400 Third, genetic differences in susceptibility to
the estrogenic effect of BPA have raised con-
cerns about subpopulations with a higher
sensitivity to this estrogen (18,21). Fourth,
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bisphenol A is not the only molecule with
proven in vitro estrogenicity that is used by
the plastics industry (24,25,54.
The leaching ofother components with
estrogenic activity from polymerized com-
posites and sealants cannot be ruled out
because sparse information is available on
their ingredients. For instance, commercial
products use dibutylphthalate (35), dioctyl-
phthalate (37), bis 2-ethylhexylphthalate,
and dicyclohexylphthalate as catalyst compo-
nents. Some of these phthalates are among
the estrogenic chemicals described by Soto et
al. (62 andJobling et al. (63).
We confirm the leaching of BPA and
other aromatic compounds from one sealant
and we present new data on biphenolic
monomers leaching from seven other
Table 3. Elution of compounds in polymerized and nonpolymerized samples of
100 mg Brillant composite (Coltene Whaledent, Alstitten, Switzerland).
Compound (pg/mL)
Treatment, pH BPA EBPA PBPA BADGE Bis-GMA Bis-DMA
Polymerized
1 - - _ _ _ _
7 - _ _ _ _ _
9 0.7 ±0.6 - - - - -
12 11.3 ±0.7 - - 9.4±0.6 22.8 0.6 -
Nonpolymerized
1 0.3±0.0 - - - - -
7 0.2±0.0 - - 1.4±0.1 - -
9 1.0±0.1 - - 2.6±0.3 - -
12 9.4±0.6 - - 15.4± 0.7 37.6 1.6 -
Table 5. Elution of compounds in polymerized and nonpolymerized samples of
100 mg Pekalux composite(Bayer, Leverkusen, Germany).
Compound (pg/mL)
Treatment,pH BPA EBPA PBPA BADGE Bis-GMA Bis-DMA
Polymerized
1 0.8±0.3 - - 51.7 ±4.4 9.7±0.7 2.8±1.5
7 0.6±0.3 - - 1.4±2.4 - -
9 0.8±0.3 - - - 2.2±0.2 26.6 ± 1.9
12 17.8±2.1 - - 4.8±0.6 2.1 ±0.3 114.9± 11.8
Nonpolymerized
1 5.8±0.6 1.5 ± 1.3 - 16.6 ± 1.4 - -
7 13.2± 1.3 4.6±0.5 10.4±1.1 24.1 ±2.1 - -
9 18.5±18.5 15.8 +0.9 6.5±0.7 2.6±0.6 4.8±0.6 -
12 10.7 ± 1.9 3.3±0.2 7.6±0.7 12.2 ± 1.2 --
Table 7. Elution of compounds in polymerized and nonpolymerized samples of
100 mg Silux composite (3M, St. Paul, MN).
Compound (pg/ml)
Treatment,pH BPA EBPA PBPA BADGE Bis-GMA Bis-DMA
Polymerized
1 0.6±0.1 1.6±0.3 - - - -
7 16.5±1.3 1.1 ±0.2 - - - -
9 5.1 ±0.2 - - 17.1 ± 1.5 - -
12 10.3±0.7 1.2±0.2 - - - -
Nonpolymerized
1 14.8 ± 1.1 30.4 ± 1.5 - 27.4 ±2.5 - -
7 16.9 ± 13.3 19.0 ±0.9 - 8.3 ± 1.3 - -
9 47.5 ±2.5 20.3±1.0 - 16.6 ± 1.3 - -
12 16.2 ± 1.0 31.8±1.5 - 2.9 ±0.3 - -
Table 9. Elution of compounds in polymerized and nonpolymerized samples of
100 mg Z-100 composite (3M, St. Paul, MN).
Compound (pg/mL)
Treatment, pH BPA EBPA PBPA BADGE Bis-GMA Bis-DMA
Polymerized
1 0.3 ±0.2 - - 3.4 0.4 - -
7 0.3 ± 0.2 - - - 5.1 ±0.4 -
9 1.5±0.4 - - 1.5±0.2 - 12.8±0.1
12 9.3±0.6 - - - - 68.3±5.1
Nonpolymerized
1 21.5 ± 1.6 - - - 204.7 10.3 -
7 24.6±1.7 - - 59.5±5.1 - -
9 37.0±3.0 - - 71.1 ±6.0 4.5±0.3 -
12 23.3 ± 1.5 - - - 44.4±2.6 -
Table 4. Elution of compounds in polymerized and nonpolymerized samples of
100 mg Charisma composite (Heraeus Kulzer,Wehrheim, Germany).
Compound (pg/mL)
Treatment, pH BPA EBPA PBPA BADGE Bis-GMA Bis-DMA
Polymerized
1 2.7±0.4 - - 3.6±0.4 4.3±0.6 3.8±0.6
7 1.4±0.3 - - 2.6±0.4 2.6±0.5 5.9±0.4
9 7.6±0.7 - - 15.7±1.5 - 7.0±0.3
12 19.5±0.5 - - 8.2±0.3 - -
Nonpolymerized
1 179.5±19.1 - - - -
7 155 ± 17.7 - - - - -
9 168± 14.1 - - - - -
12 155.3 ± 12.8 - - - - -
Table 6. Elution of compounds in polymerized and nonpolymerized samples of
100 mg Polofil composite (Voco, Cuxhaven, Germany).
Compound (pg/mL)
Treatment, pH BPA EBPA PBPA BADGE Bis-GMA Bis-DMA
Polymerized
1 0.7 ± 0.3 - - - - 4.1 ± 0.3
7 2.8±0.2 - - 7.8±0.7 12.7±0.9 -
9 2.8±0.2 - - 2.5±0.4 - 17.8±0.9
12 0.6±0.3 - - 2.9±0.3 - 12.1 ±0.9
Nonpolymerized
1 <0.2±0.1 - - - - -
7 <0.2±0.1 - - 5.5±0.5 - -
9 <0.2±0.0 - - - - -
12 <0.2±0.1 - - 2.1 ±0.2 1.5±0.2 3.2±0.3
Table 8. Elution of compounds in polymerized and nonpolymerized samples of
100 mg Tetric composite (Ivoclar, Schaan, Liechtenstein).
Compound (pg/mL)
Treatment, pH BPA EBPA PBPA BADGE Bis-GMA Bis-DMA
Polymerized
1 9.7±0.7 8.6±0.4 - 9.8±0.8 1.9±0.4 -
7 12.9± 1.0 9.6± 0.5 - 9.6± 0.8 0.4± 0.4 -
9 21.1 ±1.0 - - 105.1 ±9.5 1.4±0.4 <0.8±0.3
12 116.1 ±6.0 - - - - -
Nonpolymerized
1 1.9±0.4 - - - - -
7 - - - 13.4±1.2 - -
9 0.6± 0.6 - - 14.1 ± 1.2 - -
12 2.5± 0.3 - - 14.4± 1.2 - -
Table 10. Elution of compounds in polymerized and non-polymerized samples
of50 mg Delton sealant(Dentsply, York, PA).
Compound (pg/ml)
Treatment,pH BPA EBPA PBPA BADGE Bis-GMA Bis-DMA
Polymerized
1 6.5±0.6 39.9± 1.2 243.0± 17.9 63.7±4.6 - -
7 42.8± 2.7 8.3± 0.4 30.7± 2.1 309.0± 12.9 2.5±0.4 1.8± 0.2
9 22.5±1.4 7.4±0.4 22.5±1.6 17.4±0.9 18.5±0.4 1.3±0.2
12 28.1 ±2.0 4.1 ±0.2 19.9±2.1 60.8±4.7 1.2±0.2 0.3±0.3
Nonpolymerized
1 <0.2±0.1 - - 46.2±3.9 10.1 ±0.6 -
7 0.4±0.4 - - 2.9±0.2 31.1 ±1.4 3.4±0.3
9 5.4±0.4 - - 16.3± 1.3 1.6±0.4 -
12 - - - 15.5± 1.4 - -
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commercial composites currently used in den-
tistry. To date, reports in the literature on the
determination of products eluted from com-
posites have considered other components.
We present a study that centers on com-
poundswith documented estrogenic activity.
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